In Re Technology Licensing Corporation

423 F.3d 1286, 76 U.S.P.Q. 2d (BNA) 1450, 2005 U.S. App. LEXIS 19574, 2005 WL 2179786
CourtCourt of Appeals for the Federal Circuit
DecidedSeptember 12, 2005
Docket2005-M765
StatusPublished
Cited by23 cases

This text of 423 F.3d 1286 (In Re Technology Licensing Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Technology Licensing Corporation, 423 F.3d 1286, 76 U.S.P.Q. 2d (BNA) 1450, 2005 U.S. App. LEXIS 19574, 2005 WL 2179786 (Fed. Cir. 2005).

Opinions

Opinion for the court filed PER CURIAM.

Dissenting opinion filed by NEWMAN, Circuit Judge.

PER CURIAM.

I

This case began when Technology Licensing Corporation (“TLC”) filed a complaint against Videotek, Inc., in the United States District Court for the Northern District of California, alleging that Video-tek had infringed four patents owned by TLC. Videotek then served a complaint upon its supplier, Gennum Corporation, seeking to establish a right to indemnification in the event Videotek was held liable to TLC. In response, Gennum filed a declaratory judgment action against TLC, seeking a declaration that TLC’s asserted patents were invalid, unenforceable, and not infringed. Gennum requested a jury trial on its complaint. TLC counter[1287]*1287claimed, alleging that Gennum was liable for direct and contributory infringement of the four asserted patents. TLC and Vi-deotek then entered into a settlement agreement that resulted in a consent decree disposing of the action between those two parties. That settlement, however, did not affect Gennum’s declaratory judgment action against TLC.

Prior to the trial of the case involving Gennum and TLC, Gennum filed a motion in limine challenging TLC’s formula for measuring damages. After a hearing, the district court entered an order that had the effect of significantly reducing the amount of damages TLC would be able to recover from Gennum if infringement were found. Following that order, TLC withdrew its claim for damages for past infringement and notified the district court that it would seek only injunctive relief against future infringement. Gennum then withdrew its request for a jury trial. TLC, however, maintained that it was still entitled to a trial by jury. Noting that Gennum was seeking to invalidate the patents, TLC argued that a declaratory judgment action to invalidate a patent is an action to which the right of trial by jury attaches, regardless of the type of relief sought by the patentee. The magistrate judge, however, ruled otherwise.

The magistrate judge began by recognizing that in Tegal Corp. v. Tokyo Electron America, Inc., 257 F.3d 1331 (Fed. Cir.2001), this court held that there is no right to a jury trial when the only remedy sought by the plaintiff-patentee is an injunction and the defendant has asserted patent invalidity as an affirmative defense. The court noted that Tegal was not directly on point because in that case the issue of invalidity was asserted only as an affirmative defense and not as an independent claim. In this case, by contrast, the issue of invalidity was asserted as an independent claim (by the declaratory judgment plaintiff, Gennum). The question posed to the court was whether that distinction made a difference for purposes of the right to a jury trial.

In analyzing that issue, the magistrate judge followed this court’s decision in In re Lockwood, 50 F.3d 966 (Fed.Cir.), vacated, 515 U.S. 1182, 116 S.Ct. 29, 132 L.Ed.2d 911 (1995), which in turn relied on Tull v. United States, 481 U.S. 412, 107 S.Ct. 1831, 95 L.Ed.2d 365 (1987). The court cited those decisions for the proposition that the Seventh Amendment requires a jury trial in any action that is analogous to a suit at common law as of the time the Seventh Amendment was adopted. To resolve that question, the court noted, called for the application of a two-part test. First, a court must compare the action with the analogous action brought in the courts of England during the eighteenth century, prior to the merger of law and equity. Second, a court must look to the remedy sought and determine whether it is legal or equitable in nature. The magistrate judge stated that “application of the second prong of the Tull analysis, which pertains to the nature of the remedy sought, the most important factor for the court to consider according to Tegal, is relatively straightforward. Once TLC withdrew its claim for damages, all of the claims asserted by either party that remain to be tried are indisputably equitable in nature.” Application of the first prong of the Tull analysis, the court acknowledged, was “more challenging.” Invoking this court’s decision in Lockivood, the magistrate judge explained that, at common law, allegations of patent infringement could be raised either in an action at law or in a suit in equity. The choice of forum and remedy, and thus of the method of trial, was left to the patentee. If the patentee sought only damages, he filed an action in a court of law. If he sought only to enjoin future acts of infringement, he could only bring a suit in equity.

[1288]*1288The magistrate judge concluded that an action for a declaratory judgment of invalidity in which a counterclaim of infringement has been filed is most closely analogous to an action at common law for infringement in which a defense of invalidity was asserted. Accordingly, in determining whether the action was triable to a jury, the court looked to whether the patentee had sought damages or only an injunction, which would have been the dis-positive question at common law for purposes of determining whether the action could be brought at law or in equity. Because TLC was seeking only equitable relief, the court concluded that the action would have been brought in equity, and that no jury trial would have been available. For that reason, the court ruled, TLC was not entitled to a jury trial in this case.

TLC petitioned this court for a writ of mandamus to compel the district court to grant its request for a jury trial. Because “the right to grant mandamus to require jury trial where it has been improperly denied is settled,” Beacon Theatres, Inc. v. Westover, 359 U.S. 500, 511, 79 S.Ct. 948, 3 L.Ed.2d 988 (1959), we have entertained TLC’s mandamus petition in order to decide whether the district court erroneously denied TLC’s request for a jury trial. See also Dairy Queen, Inc. v. Wood, 369 U.S. 469, 472, 82 S.Ct. 894, 8 L.Ed.2d 44 (1962) (noting “the responsibility of the Federal Courts of Appeals to grant mandamus where necessary to protect the constitutional right to trial by jury”). Although we, like the magistrate judge, consider the issue to be close, we concur in the analysis and conclusion reached by the magistrate judge that TLC was not entitled to a jury trial under our decisions and those of the Supreme Court. We therefore deny the petition for mandamus.

II

This court’s decision in Tegal is analogous to this case in some respects, but not all. In Tegal, the plaintiff filed an action for patent infringement but sought only an injunction by way of relief. The defendant raised the affirmative defense of invalidity. The district court denied the plaintiffs request for a jury trial, and this court upheld that decision. We held that a jury trial was not available because the plaintiff had sought only an equitable remedy and because in an analogous action in eighteenth century England, the patentee’s decision to seek only an injunction would require that the suit be brought in equity, not at law. Tegal, 257 F.3d at 1340 (“[Gjiven Tegal’s interest only in an injunction, it is clear that Tegal would have needed, in eighteenth century England, to bring its case in a court of equity.”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Fjord v. AMR Corp. (In re AMR Corp.)
506 B.R. 368 (S.D. New York, 2014)
Medtronic Inc. v. Boston Scientific Corp.
695 F.3d 1266 (Federal Circuit, 2012)
Duhn Oil Tool, Inc. v. Cooper Cameron Corp.
818 F. Supp. 2d 1193 (E.D. California, 2011)
Medtronic, Inc. v. Boston Scientific Corp.
587 F. Supp. 2d 648 (D. Delaware, 2008)
Technology Licensing Corp. v. Videotek, Inc.
545 F.3d 1316 (Federal Circuit, 2008)
MedImmune, Inc. v. Genentech, Inc.
535 F. Supp. 2d 1020 (C.D. California, 2008)
Hynix Semiconductor Inc. v. Rambus, Inc.
527 F. Supp. 2d 1084 (N.D. California, 2007)
Hodge v. Superior Court
51 Cal. Rptr. 3d 519 (California Court of Appeal, 2006)
Agfa Corp. v. Creo Products, Inc.
451 F.3d 1366 (Federal Circuit, 2006)
Agfa Corporation v. Creo Products Inc.
451 F.3d 1366 (Federal Circuit, 2006)
In re Impax Laboratories, Inc.
171 F. App'x 839 (Federal Circuit, 2006)
02 Micro International Ltd. v. Monolithic Power System, Inc.
399 F. Supp. 2d 1064 (N.D. California, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
423 F.3d 1286, 76 U.S.P.Q. 2d (BNA) 1450, 2005 U.S. App. LEXIS 19574, 2005 WL 2179786, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-technology-licensing-corporation-cafc-2005.